Advocate Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Advocate Group's MRK Position: Q3 2026 in Review
Advocate Group reduced its Merck (MRK) stake by 20% in Q3 2026, selling an estimated $2.45M and leaving 72,809 shares worth $10.6M. The position accounts for 1.64% of the portfolio, ranked #14.
Advocate Group first reported a position in MRK in Q2 2022 and has held it in 18 quarters since. The position peaked at $11.7M in Q1 2026. 1,812 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Advocate Group held 72,809 shares of Merck worth $10.6M as of Q3 2026.
- Advocate Group sold 17,763 Merck shares in Q3 2026, an estimated $2.45M.
- Merck made up 1.64% of Advocate Group's portfolio in Q3 2026, its #14 holding.
- Advocate Group first reported a position in Merck in Q2 2022 and has held it in 18 quarters since.
- Advocate Group's Merck position peaked at $11.7M in Q1 2026.
- 1,812 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Advocate Group's 13F filing for Q3 2026, filed 19 Oct 2026.